[go: up one dir, main page]

NO20014362L - Erytromycinderivater - Google Patents

Erytromycinderivater

Info

Publication number
NO20014362L
NO20014362L NO20014362A NO20014362A NO20014362L NO 20014362 L NO20014362 L NO 20014362L NO 20014362 A NO20014362 A NO 20014362A NO 20014362 A NO20014362 A NO 20014362A NO 20014362 L NO20014362 L NO 20014362L
Authority
NO
Norway
Prior art keywords
erythromycin derivative
erythromycin
derivative
Prior art date
Application number
NO20014362A
Other languages
English (en)
Other versions
NO20014362D0 (no
Inventor
Hideo Kato
Noriyuki Kado
Toshihiko Yoshida
Akemi Nishimoto
Ken Narita
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of NO20014362D0 publication Critical patent/NO20014362D0/no
Publication of NO20014362L publication Critical patent/NO20014362L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20014362A 1999-04-08 2001-09-07 Erytromycinderivater NO20014362L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10072699 1999-04-08
PCT/JP2000/002226 WO2000061593A1 (fr) 1999-04-08 2000-04-06 Derives d'erythromycine

Publications (2)

Publication Number Publication Date
NO20014362D0 NO20014362D0 (no) 2001-09-07
NO20014362L true NO20014362L (no) 2001-12-04

Family

ID=14281635

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014362A NO20014362L (no) 1999-04-08 2001-09-07 Erytromycinderivater

Country Status (19)

Country Link
EP (1) EP1167375A4 (no)
KR (1) KR20020007333A (no)
CN (1) CN1343216A (no)
AR (1) AR023264A1 (no)
AU (1) AU3671000A (no)
BG (1) BG105919A (no)
BR (1) BR0010518A (no)
CA (1) CA2367319A1 (no)
CZ (1) CZ20013497A3 (no)
HK (1) HK1045697A1 (no)
HU (1) HUP0201116A3 (no)
IL (1) IL145256A0 (no)
NO (1) NO20014362L (no)
NZ (1) NZ513998A (no)
PL (1) PL354409A1 (no)
SK (1) SK13972001A3 (no)
TR (1) TR200102572T2 (no)
WO (1) WO2000061593A1 (no)
ZA (1) ZA200107346B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312839T1 (de) * 2000-02-24 2005-12-15 Abbott Lab Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2002173498A (ja) * 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
UY27429A1 (es) * 2001-09-05 2003-10-31 Hokuriku Pharmaceutical Medicamento para el tratamiento terapéutico o preventivo de la tuberculosis que comprende un derivado de eritromicina
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CA2799937A1 (en) * 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
WO2014166503A1 (en) * 2013-04-10 2014-10-16 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
HUT42502A (en) * 1985-03-12 1987-07-28 Beecham Group Plc Process for preparing new erythromycine derivatives
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
PL354409A1 (en) 2004-01-12
TR200102572T2 (tr) 2002-02-21
HUP0201116A2 (en) 2002-08-28
BG105919A (en) 2002-06-28
HK1045697A1 (zh) 2002-12-06
AR023264A1 (es) 2002-09-04
IL145256A0 (en) 2002-06-30
HUP0201116A3 (en) 2003-03-28
EP1167375A4 (en) 2002-10-30
BR0010518A (pt) 2002-01-08
NZ513998A (en) 2001-09-28
ZA200107346B (en) 2002-11-27
KR20020007333A (ko) 2002-01-26
EP1167375A1 (en) 2002-01-02
CA2367319A1 (en) 2000-10-19
CZ20013497A3 (cs) 2002-05-15
NO20014362D0 (no) 2001-09-07
AU3671000A (en) 2000-11-14
CN1343216A (zh) 2002-04-03
SK13972001A3 (sk) 2002-08-06
WO2000061593A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
IS2116B (is) 4-fenyl-pyridin afleiður
NO20021077D0 (no) Amino-triazolopyridin-derivater
ATE263748T1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
NO20015172D0 (no) 1-Metyl-erytromycin-derivater
DK1147121T3 (da) Ketolidantibiotika
ATE377018T1 (de) Erythromycinderivate
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
NO20021803D0 (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
NO20014362L (no) Erytromycinderivater
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
DK1218340T3 (da) 4-hydroxybiphenylhydrazid-derivater
ATE293592T1 (de) Resorcinderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
PT1088818E (pt) Derivados de quinolin-4-ilo
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
PT1194401E (pt) Derivados de diacil-hidrazina
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
NO20015380D0 (no) Tio-oksindolderivater
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application